GlaxoSmithKline, Europe’s largest drugmaker, named 43-year-old Briton Andrew Witty as its new chief executive. Witty takes the helm from Frenchman Jean-Pierre Garnier next May. “He has the luxury of time, since he could be there for the best part of 20 years,” said analyst Peter Cartwright at Evolution Securities. (Reuters)
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
Join more than 350,000 subscribers and keep yourself informed with a selection of The Week’s most interesting, enlightening and entertaining stories - plus daily puzzles.
Join more than 350,000 subscribers and keep yourself informed with a selection of The Week’s most interesting, enlightening and entertaining stories - plus daily puzzles.